Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pharmacokinetics, efficacy, and safety of subcutaneous ve... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pharmacokinetics, efficacy, and safety of subcutaneous versus intravenous rituximab in previously untreated Chinese patients with CD20+ diffuse large B-cell lymphoma: a phase II randomized controlled trial
0
Authors
Yan Gao
13 more
Yan Gao
•
Sujun Gao
11 more
•
Huiqiang Huang
Published
January 7, 2025
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Leukemia & lymphoma/Leukemia and lymphoma
Topics
Medicine
Cancer Oncology
Internal Medicine
Pathology And Forensic Medicine
Genetics
Show all topics
DOI
10.1080/10428194.2024.2439525
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Leukemia & lymphoma/Leukemia and lymphoma
Topics
Medicine
Cancer Oncology
Internal Medicine
Pathology And Forensic Medicine
Genetics
Show all topics
DOI
10.1080/10428194.2024.2439525
License
CC-BY-NC-ND
